TGTX Earnings

Quarterly EPS
$0.03
Q3 2024
$0.16
Q4 2024
$0.03
Q1 2025
$0.19
Q2 2025
$2.69
Q3 2025
$0.17
Q4 2025
$0.14
Q1 2026
$0.05
Q2 2026
Latest Revenue240.3M
Latest Net Income7.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.05240.3M7.8M+70.3%-73.7%
Q1 2026$0.14204.9M19.8M+69.6%+366.7%
Q4 2025$0.17192.6M23.0M+78.0%+6.3%
Q3 2025$2.69161.7M390.9M+92.8%+8,866.7%
Q2 2025$0.19141.1M28.2M+92.1%+280.0%
Q1 2025$0.03120.9M5.1M+90.4%+142.9%
Q4 2024$0.16108.2M23.3M+146.0%+260.0%
Q3 2024$0.0383.9M3.9M-49.4%-96.3%
Q2 2024$0.0573.5M6.9M
Q1 2024-$0.0763.5M-10707000
Q4 2023-$0.1044.0M-14416000
Q3 2023$0.80165.8M113.9M
TG Therapeutics (TGTX) — Earnings